16 June 2004
T2-hyperintense foci on brain MR imaging
Monika Bekiesińska-FigatowskaMed Sci Monit 2004; 10(3): 80-87 :: ID: 11870
Abstract
Background:T2-hyperintense foci are one of the most frequent findings in cerebral magnetic resonance imaging (MRI). They can pose serious diagnostic problems which is reflected by their English name and abbreviation – UBOs (Unidentified Bright Objects).Material/Methods: Cerebral MRI results of 246 patients (134 females, 112 males), aged 2 –79 years, were analyzed. The examinations were done with the 0.5 and 1.5 T MRI scanners. T1-, PD or FLAIR and T2-weighted images were obtained. Diffusion-weighted imaging (DWI) was also performed in a high field system.Results: The following diagnoses were established: widened perivascular spaces in 11 cases, foci most probably associated with brain aging –21, with migraine –15, ischaemic changes –52, vasculitis –12, hypoxic-ischaemic changes –8, haemorrhagic foci –11, inflammatory changes –20, multiple sclerosis –50, central pontine and extrapontine myelinolysis –7, metastases –7, changes caused by radio-and chemotherapy – 8, lesions associated with neurometabolic diseases – 10, CNS degenerative diseases – 13, eclampsia – 1.Conclusions: MRI is a sensitive method of CNS focal lesions detection but is less specific as far as their differentiation is concerned. Particular features of the focal lesions on MR images (number, size, location, presence or lack of edema, reaction to contrast medium, evolution in time), as well as accompanying features (atrophy of particular brain structures, postcontrast enhancement of leptomeninges, coexistence of diffuse lesions, coexistence of spinal lesions) are the significant differentiating elements. However, they can not be considered in isolation from clinical data and other diagnostic tests results.
Keywords: T2--hyperintensities, MRI, Brain
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952